The Medicines Transparency Alliance: Making a Difference to People’s Health Alliance pour la transparence du médicament: une contribution majeure à la.

Slides:



Advertisements
Similar presentations
Regulation of Pharmaceutical Promotion: assessment, analysis & advocacy Lilia Ziganshina 20 May 2009 WHA.
Advertisements

Strategies to Improve Efficiency in Medicine Procurement Towards equitable and affordable medicine prices policies in Jordan Workshop 4-5 Dec, 2007 Dr.
1 HAI conference Medicines for Europe and the World Setting priorities: missing the point A rational medicines policy for Europe A rational.
1 MDG Target 8.E gap analysis Dr Hans Hogerzeil Director, Department of Essential Medicines and Pharmaceutical Policies, World Health Organization October.
The WHO Medicines Strategy Richard Laing Based on materials produced by Hans V. Hogerzeil, Essential Medicines and Pharmaceutical Policies November.
World Meteorological Organization Working together in weather, climate and water WMO OMM WMO Climate & Water Department SIDE EVENTS on GLOBAL.
The Alliance for the Advancement of Heritage Languages.
Promoting patient-centred healthcare around the world Advancing the fight against counterfeit medicines Ms. Regina Kamoga IAPO Board Member, Country Manager,
Promoting patient-centred healthcare around the world Counterfeit Medicines: The views and role of patients and patients’ organizations Jo Harkness Policy.
STRUCTURE. Nominate and Approve BOARD members Member Organisations (Sanctuary or Community Custodians) } } …and EMT members } Approve New Member Orgs.
Law Enforcement and Corporate Accountability Setting the Scene David Bergman.
State Health Departments: Focused on the Next Level Ann Robbins Texas Department of State Health Services National Alliance of State and Territorial AIDS.
Thailand National Focal Point for IFCS Chemical Safety Section Food and Drug Administration Ministry of Public Health July 2003.
King Saud Bin Abdulaziz University for Health Sciences COLLEGE OF MEDICINE DEPARTMENT OF MEDICAL EDUCATION.
Medicines Transparancy Alliance workshop in N/Western and C/B Provinces August 2013, Lusaka 22 October 2013, Kabwe 18 July 2014 and Livingstone 28 July.
Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles.
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
WHO Good Governance for Medicines programme Technical Briefing Seminar 19 November 2009, Geneva Dr Guitelle Baghdadi-Sabeti Department of Essential Medicines.
Good Governance for Medicines Programme: the Thai Experience Dr.Chanvit Tharathep. Director of HSSD Bureau, Department of HSS MOPH,Thailand.
Transport.tamu.edu Slow Moving Vehicle (SMV) Task Force Presented to TSAC February 6, 2013.
WELCOME TO THE ECSU, School of Education and Professional Studies! LEARN ABOUT OUR BUSINESS RELATED MAJORS ACCOUNTING BUSINESS ADMINISTRATION BUSINESS.
Thirty Eight APEC Transportation Working Group Meeting, Bali, Indonesia 1 – 5 July 2013 Thirty Eight APEC Transportation Working Group Meeting, Bali, Indonesia.
MeTA Jordan Executive Summary Baseline data is an important source for policy makers to diagnose the pharmaceutical and health sector situation in order.
MULTI-STAKEHOLDER COLLABORATION: CAN IT IMPROVE TRANSPARENCY, DISCLOSURE AND ACCESS TO MEDICINES? EXPERIENCES FROM 7 META PILOT COUNTRIES Wilbert Bannenberg.
Wilbert Bannenberg, Technical Director MeTA International Secretariat IACC 14 Bangkok, 13 November 2010 MeTA multi-stakeholder process – a way to improve.
Wilbert Bannenberg SARPAM
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
1 Makerere University School of Public Health, Kampala, UGANDA Disaster Preparedness and Response Dr Christopher Garimoi Orach PHREEway Consultation Meeting.
ITU Regional Standardization Forum for Americas (Washington D.C., United States, 21 September 2015) US International Telecommunication Advisory Committee.
The New Public Health System
Controlling and Eradicating Highly Pathogenic Avian Influenza in ASEAN Dr. Wilfrido V. Villacorta ASEAN Deputy Secretary-General International Pledging.
Defence Intelligence THE DEFENCE INTELLIGENCE STAFF UK Strategic Intelligence, Planning and Decision Making.
Group 5 : Food Safety and Quality
16 May 2008 Hon Francisco T. Duque Secretary Department of Health MeTA Philippines: Sharing Responsibility, Achieving as One MeTA1.
Samia Saad 1, Birgit Kerstens 2, Wilbert Bannenberg 1,2 1 Medicines Transparency Alliance (MeTA) Pilot, United Kingdom; 2 Health Research for Action (HERA),
Report from WMO Secretariat - Membership - Terms of Reference - Organizing Structure - Timeline of OSC RES/WWRD.
WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO round table on access to medicines.
Enhancing Public Health, Health Care System, and Clinician Preparedness: Strategies to Promote Coordination and Communication Edward J. Gabriel, M.P.A.,
HomeGovernancePolicy documentsScientific panelThematic working groupsKnowledge networkCountry profiles Country Profiles The Third Ministerial Meeting in.
Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia.
Ministry of Health THE ESTABLISHMENT OF TECHNICAL WORKING GROUPS IN HPG Presentation: Dr. Tran Thi Giang Huong Director of International Cooperation Department,
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
Medicines Transparency Alliance27/10/ MeTA Ghana Augustina Koduah (Mrs) Country Coordinator.
MeTA Medicines Transparency Alliance: Under New Management Dr Tim Reed Director, Health Action International (Global) International MeTA Secretariat.
People Directorate The Education Horizon Paul Jacobs, Service Director for Education & Skills, Bristol City Council.
Medicines systems: Convergence for access Dr Socorro Escalante WHO Country Office for Viet Nam 1.
European Health Forum Gastein 7 October 2004 – Lunch Workshop L1 “Towards a health competent consumer: policy action for improved health information” Anne.
October 19, 2010 Hospital to Home Call 1
Medicines Transparency Alliance18/12/ Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator.
Implementation of the Affordable Care Act: Opportunities for Collaboration and Partnership Herb K. Schultz Regional Director, DHHS, Region IX Santa Clara.
Strategic Governance In Hungary Case of Prime Ministers Office Dr. Istvan Stumpf President of Szazadveg Foundation Former Minister.
Wilbert Bannenberg & Elodie Brandamir Technical & Operational Directors MeTA International Secretariat MeTA Kyrgyzstan Forum Bishkek, 16 April 2009 Medicines.
Wilbert Bannenberg Technical Director, Intl MeTA Secretariat 28 April 2010, IPC meeting, Copenhagen Medicines Transparency Alliance: improving people’s.
HIPAA COMPLIANCE IN WASHINGTON STATE Vicki Hohner Washington State Dept. of Health March 15, 2002.
2015 Commonwealth Fund International Health Policy Survey of Primary Care Physicians March 1, 2016.
Medicines Transparency Alliance12/06/ MeTA Peru Germán Rojas, Technical Secretary Leda M. Perez, Consultant to MeTA in Peru.
LOGO 21 st APLMF Forum meeting Wellington, New Zealand Nov. 11, 2014 APLMF Secretariat Report.
VULNERABILITY AND ADAPTATION EFFORTS: The Philippine Experience Ms. Gigi Merilo InterAgency Committee on Climate Change Secretariat Environmental Management.
SADC Medicines Database (SMD)
2016 Commonwealth Fund International Health Policy Survey of Adults in Eleven Countries May 18th, 2017.
Wilbert Bannenberg SARPAM
The Tyranny of Privacy: Balancing Rights and Public Health
Regional Training Unit and Health Promotion Agency
سياسة الإفصاح والشفافية ببنك التنمية الصناعية
Dr Yao (WHO-CI) Dr N’Guessan-Irié (DPM)
Good Governance for Medicines
Mr. Cleveland Thomas Vice Chairman Working Party 2/3 Study Group 3 ITU-T.
CONTACT US My Best Natural Health
OIE’s fourth Strategic Plan
Presentation transcript:

The Medicines Transparency Alliance: Making a Difference to People’s Health Alliance pour la transparence du médicament: une contribution majeure à la santé MeTA23/04/20151 In collaboration with:

23/04/2015MeTA2 Speakers Dr Gabriel Scally, Regional Director Public Health, Dept of Health Dr Carisse Etienne, Ass Director general, WHO Mr Andrew Chetley, Communication Director, MeTA Hon. Dr Francisco Duque, Secretary of Health, Philippines Mrs Guitelle Baghdadi, Coordinator, Good Governance for Medicines Programme, WHO Dr Chanvit Tharathep, Director Bureau of Health Services System Devt, Min of Public Health, Thailand

23/04/2015MeTA3 Panellists Dr Hans Hogerzeil, Director, Department of Medicines Policy and Standards, WHO Dr Harvey Bale, Director-General of the International Federation of Pharmaceutical Manufacturers and Associations Ms Marg Ewen, Coordinator, WHO/HAI Project on Medicine Prices, Health Action International

23/04/2015MeTA4 More information Contact the MeTA Secretariat – International Secretariat, – Wilbert Bannenberg, – Garth Singleton, – Andrew Chetley, –